Christine Lee, PhD

Faculty Appointment(s)

Research Professor

Leadership Role(s)

Associate Director, Center for the Study of Health and Risk Behaviors

Co-Director, BASICS Innovations Group

leecm@uw.edu

206-543-6574

Personal Statement

The transition to adulthood is the developmental period when alcohol use, marijuana use, and their associated consequences reach their lifetime peak. My scholarly interests focus on the etiology and prevention of substance use behaviors and consequences during adolescence and young/early adulthood. I have developed a highly successful portfolio of work bridging developmental, social, and motivational theory with applied prevention and intervention techniques to strategically address high-risk behaviors during the transition to adulthood. My research addresses important questions regarding how recent marijuana legislation in Washington State impacts young adult marijuana use and consequences; what motivates young adults to engage in alcohol and marijuana use; how alcohol expectancies, alcohol use and consequences are linked in a natural feed-forward process that maintains high-risk behaviors; how developmental transitions and event timing influence use; and what are efficacious prevention and intervention strategies and for whom and under what conditions are these most effective.

Department Affiliations

Centers/Programs
Training Programs

Recent Publications

Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.
(2026 Mar 18)
JAMA Dermatol
Kimball AB, Sawicki KT, Ackerman L, Lima H, Giamarellos-Bourboulis EJ, Zhan T, Drogaris L, Gu Y, Lee CM, Akbari M, Williams DA, Bechara FG
Building safeguards for gene therapy in haemophilia.
(2026 Mar 10)
Lancet Haematol
Uminski K, Lee CA, Hermans C
Cannabis Use Problems Moderate Daily Associations between Cannabis Consequences and Subsequent Use.
(2026 Mar 10)
J Stud Alcohol Drugs
Dyar C, Rhew IC, Lee CM
Daily Life Assessment of Seven Alcohol-Use-Disorder Symptoms.
(2026 Mar 1)
Clin Psychol Sci
Kang D, Watts AL, Boness CL, Schultz ME, Dora J, Lee CM, King KM
Tumor antigen only (TAO) vaccine platforms for glioblastoma therapeutics: a systematic review of evidence from clinical trials.
(2026 Mar)
EClinicalMedicine 93(): 103774
Chen HC, Wong ET, Sarangi S, Elinzano H, Kuburich NA, Mani SA, Ali R, Cielo D, Svokos KA, Sampath P, Malik AN, Lee CK, Doberstein CE, Lawler SE, Seyhan A, El-Deiry WS, Chen CC
Show complete publication list »
Edit Profile